 Jennifer Cimons
Concepts (60)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Immunotherapy, Adoptive | 3 | 2025 | 342 | 1.020 |
Why?
| | T-Box Domain Proteins | 1 | 2025 | 106 | 0.840 |
Why?
| | CD8-Positive T-Lymphocytes | 3 | 2025 | 917 | 0.310 |
Why?
| | B-Lymphocytes | 2 | 2025 | 878 | 0.260 |
Why?
| | Immunologic Memory | 2 | 2025 | 368 | 0.230 |
Why?
| | Sialic Acid Binding Ig-like Lectin 2 | 1 | 2025 | 21 | 0.230 |
Why?
| | Xenograft Model Antitumor Assays | 2 | 2025 | 929 | 0.220 |
Why?
| | Leukemia | 2 | 2025 | 246 | 0.220 |
Why?
| | Cell Line, Tumor | 3 | 2025 | 3537 | 0.190 |
Why?
| | Receptors, Antigen, T-Cell | 2 | 2017 | 673 | 0.190 |
Why?
| | Mice | 6 | 2025 | 18338 | 0.140 |
Why?
| | Allergens | 1 | 2020 | 390 | 0.130 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2017 | 203 | 0.110 |
Why?
| | Protein Engineering | 1 | 2016 | 123 | 0.110 |
Why?
| | Histones | 1 | 2020 | 663 | 0.110 |
Why?
| | Autoimmunity | 1 | 2020 | 936 | 0.100 |
Why?
| | HIV-1 | 1 | 2020 | 905 | 0.100 |
Why?
| | Cytotoxicity, Immunologic | 2 | 2025 | 226 | 0.100 |
Why?
| | Animals | 6 | 2025 | 38141 | 0.100 |
Why?
| | Software | 1 | 2017 | 698 | 0.090 |
Why?
| | Peptides | 1 | 2017 | 993 | 0.080 |
Why?
| | Databases, Factual | 1 | 2017 | 1500 | 0.080 |
Why?
| | Protein Binding | 3 | 2025 | 2250 | 0.080 |
Why?
| | Mutation | 2 | 2017 | 4093 | 0.070 |
Why?
| | Forkhead Box Protein O1 | 1 | 2025 | 35 | 0.050 |
Why?
| | Antigens, CD19 | 1 | 2025 | 130 | 0.050 |
Why?
| | Core Binding Factor Alpha 1 Subunit | 1 | 2025 | 45 | 0.050 |
Why?
| | T-Lymphocytes | 2 | 2025 | 1996 | 0.050 |
Why?
| | HIV Infections | 1 | 2020 | 3189 | 0.050 |
Why?
| | Granzymes | 1 | 2024 | 49 | 0.050 |
Why?
| | Protein Domains | 1 | 2025 | 314 | 0.050 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2025 | 296 | 0.050 |
Why?
| | Humans | 6 | 2025 | 145491 | 0.050 |
Why?
| | Hemagglutination | 1 | 2020 | 7 | 0.040 |
Why?
| | Peripheral Tolerance | 1 | 2020 | 14 | 0.040 |
Why?
| | COS Cells | 1 | 2020 | 177 | 0.040 |
Why?
| | Receptors, Antigen, B-Cell | 1 | 2020 | 133 | 0.040 |
Why?
| | Tumor Microenvironment | 1 | 2024 | 737 | 0.040 |
Why?
| | Toll-Like Receptors | 1 | 2020 | 193 | 0.040 |
Why?
| | Immunoglobulin M | 1 | 2020 | 282 | 0.040 |
Why?
| | Immunization | 1 | 2020 | 375 | 0.030 |
Why?
| | Antibodies, Neutralizing | 1 | 2020 | 342 | 0.030 |
Why?
| | Autoantigens | 1 | 2020 | 426 | 0.030 |
Why?
| | Host-Pathogen Interactions | 1 | 2020 | 369 | 0.030 |
Why?
| | HLA-A2 Antigen | 1 | 2016 | 36 | 0.030 |
Why?
| | Protein Structure, Secondary | 1 | 2016 | 366 | 0.030 |
Why?
| | Ligands | 1 | 2017 | 667 | 0.030 |
Why?
| | Thermodynamics | 1 | 2017 | 427 | 0.030 |
Why?
| | Cell Line | 1 | 2020 | 2823 | 0.030 |
Why?
| | Molecular Dynamics Simulation | 1 | 2016 | 266 | 0.030 |
Why?
| | Mice, Inbred C57BL | 1 | 2025 | 5989 | 0.030 |
Why?
| | Protein Conformation | 1 | 2017 | 935 | 0.030 |
Why?
| | Binding Sites | 1 | 2017 | 1313 | 0.020 |
Why?
| | Antibodies, Monoclonal | 1 | 2020 | 1511 | 0.020 |
Why?
| | Signal Transduction | 1 | 2025 | 5202 | 0.020 |
Why?
| | Internet | 1 | 2017 | 701 | 0.020 |
Why?
| | Models, Molecular | 1 | 2017 | 1614 | 0.020 |
Why?
| | Computational Biology | 1 | 2016 | 687 | 0.020 |
Why?
| | Male | 1 | 2025 | 72817 | 0.010 |
Why?
| | Female | 1 | 2025 | 78763 | 0.010 |
Why?
|
|
Cimons's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|